Cargando…

Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?

OBJECTIVES: Vascular endothelial growth factor (VEGF) is involved in physiological angiogenesis, but also is considered one of the key factors that promotes tumor angiogenesis. CIGB-247 is a VEGF-based vaccine that has been evaluated in phase I clinical trial patients with advanced solid tumors. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez Ramírez, Javier, Bequet-Romero, Mónica, Morera Díaz, Yanelys, Hernández-Bernal, Francisco, Ayala Avila, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558718/ https://www.ncbi.nlm.nih.gov/pubmed/31182141 http://dx.doi.org/10.1186/s13104-019-4368-z

Ejemplares similares

Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
por: Sánchez Ramírez, Javier, et al.
Publicado: (2018)

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program
por: Sánchez Ramírez, Javier, et al.
Publicado: (2020)

Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants
por: Sánchez Ramírez, Javier, et al.
Publicado: (2017)

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015)

The umbilical cord, preeclampsia and the VEGF family
por: Olaya-C, Mercedes, et al.
Publicado: (2018)

VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process
por: Capossela, Simona, et al.
Publicado: (2018)

Expression of VEGF in Neonatal Urinary Obstruction: Does Expression of VEGF Predict Hydronephrosis?
por: Magyar, Zsófia, et al.
Publicado: (2015)

Blood platelets and serum VEGF in cancer patients
Publicado: (1999)

Platelets and VEGF blood levels in cancer patients
por: Gunsilius, E, et al.
Publicado: (1999)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023)

Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV?
por: Boltz, Agnes, et al.
Publicado: (2010)

Human Platelets Take up Anti-VEGF Agents
por: Sobolewska, B., et al.
Publicado: (2021)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer
por: Itatani, Yoshiro, et al.
Publicado: (2020)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012)

Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
por: Parveen, Amna, et al.
Publicado: (2019)

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
por: van Beijnum, Judy R., et al.
Publicado: (2022)

Does anti-VEGF bevacizumab improve survival in experimental sepsis?
por: Besnier, Emmanuel, et al.
Publicado: (2017)

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
por: Pritchard-Jones, R O, et al.
Publicado: (2007)

Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
por: Kut, C, et al.
Publicado: (2007)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Computational Modeling of Interacting VEGF and Soluble VEGF Receptor Concentration Gradients
por: Hashambhoy, Yasmin L., et al.
Publicado: (2011)

When VEGF strays
por: Leslie, Mitch
Publicado: (2007)

Vessel-widening by VEGF
por: Bashyam, Hema
Publicado: (2007)

Diabetic Retinopathy and VEGF
por: Gupta, N, et al.
Publicado: (2013)

VEGF involvement in psoriasis
por: MARINA, MIHAELA ELENA, et al.
Publicado: (2015)

Anti-VEGF and Beyond
por: Bertelmann, T., et al.
Publicado: (2017)

Painful Understanding of VEGF
por: Llorián-Salvador, María, et al.
Publicado: (2018)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue
por: Marisi, Giorgia, et al.
Publicado: (2014)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2012)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Genetic Variation in VEGF Does Not Contribute Significantly to the Risk of Congenital Cardiovascular Malformation
por: Griffin, Helen R., et al.
Publicado: (2009)

Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers
por: Brouwers, Judith, et al.
Publicado: (2013)

Methodological variations affect the release of VEGF in vitro and fibrinolysis’ time from platelet concentrates
por: de Oliveira, Leonel Alves, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qbclp9qilluivjb3v00mpfus88